Imitrex / Sumatriptan Succinate

Modified on 2009/10/14 21:46 by admin
Imitrex, also known as Sumatriptan Succinate, is used for the treatment of severe migraine headaches. Introduced by GlaxoSmithKline in 1993, Imitrex targets the nerves and blood vessels that trigger the throbbing pain associated with a migraine headache. The drug often relieves other symptoms that occur together with a migraine, such as nausea, vomiting, sensitivity to light, and sensitivity to sound.

The drug can be administered in three forms (tablet, injection, or nasal spray) and is available by prescription only. Patients whose headaches are not relieved by acetaminophen, aspirin, or other pain relievers usually use Imitrex. Stroke patients should use caution if using Imitrex.

Imitrex Side Effects: Glaxo recently changed package labeling for the drug to include a warning stating that deaths attributed to myocardial infarction and cerebrovascular events have occurred within a few hours of Imitrex use. Users with risk factors for heart disease should consult a doctor before using Imitrex. Imitrex and stroke have also been linked.

See your doctor if you have experienced serious health problems after taking Imitrex. In addition, it may be important to contact an Imitrex lawyer who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

See Also

  1. Painkillers: Overview
  2. Heart Attack Lawsuits
  3. High Blood Pressure (hypertension): Overview
  4. Ischemic Colitis: Overview
  5. Stroke
  Name Size